In addition, we not only elucidated the expression and prognostic value of RFX1 in colon cancer using multi-omics analysis, but also innovatively introduced persistent tumor mutational burden (pTMB) as a co-stratification tool. Here, RFX1 is linked to malignant colon neoplasm.